You are here

Verona Pharma

Verona says COPD drug is off to a flying start

Pharmaphorum

Tue, 01/7/25 - 10:29 am

FDA approves Verona Pharma's inhaled COPD therapy

Reuters

Thu, 06/27/24 - 11:35 am

Verona Gears Up for First Novel COPD Approval in Over a Decade

BioSpace

Tue, 06/25/24 - 11:12 am

Verona Secures Up To $650M in Funding as it Gears Up for Potential COPD Approval and Launch

BioSpace

Fri, 05/10/24 - 11:28 am

COPD Market Poised for ‘Paradigm Shift’ with Potential Approvals in 2024

BioSpace

Wed, 03/27/24 - 11:06 am

4 biotechs to watch in 2024

Pharma Voice

Wed, 02/21/24 - 11:28 am

Alto Neuroscience

Karuna Therapeutics

Madrigal Pharmaceuticals

precision medicine

Alzheimer's disease

Verona Gets $400M Boost from Oxford Finance, Hercules Capital for COPD Candidate

BioSpace

Wed, 01/3/24 - 09:51 am

Verona Pharma Eyes NDA for COPD Drug Based on Positive Phase III Data

BioSpace

Wed, 12/21/22 - 12:00 am

On heels of positive COPD readout, Verona to provide new public offering

Endpoints

Wed, 08/10/22 - 10:38 am

clinical trials

Boost for Verona Pharma after trial win with inhaled COPD drug

Pharmaforum

Tue, 02/2/21 - 10:37 am

clinical trials

Verona to test COPD hopeful ensifentrine in COVID-19 patients

Pharmaforum

Tue, 09/8/20 - 10:30 pm

Verona Pharma to trial lung drug ensifentrine for COVID-19

Pharmaforum

Fri, 08/14/20 - 09:46 am

Verona hires ex-GSK researchers for late-phase push in COPD

Fierce Biotech

Tue, 06/25/19 - 09:17 am